Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
Congenital dyserythropoietic anemia type II or hereditary erythroblastic multinuclearity with positive acidified serum test (HEMPAS) is a genetic disease caused by membrane abnormality. Previously we have found that Band 3 and Band 4.5 are not glycosylated by lactosaminoglycans in HEMPAS erythrocytes, whereas normally these proteins have lactosaminoglycans (Fukuda, M. N., Papayannopoulou, T., Gordon-Smith, E. C., Rochant, H., and Testa, U. (1984) Br. J. Haematol. 56, 55-68). In order to find out where glycosylation of lactosaminoglycans stops, we have analyzed the carbohydrate structures of HEMPAS Band 3. By fast atom bombardment-mass spectrometry, methylation analysis, and hydrazinolysis followed by exoglycosidase treatments, the following structure was elucidated: (formula; see text) N-Linked glycopeptides synthesized in vitro by reticulocyte microsomes from HEMPAS were shown to be predominantly the above short oligosaccharide, whereas those from normal reticulocytes contain large molecular weight carbohydrates. The N-acetylglucosaminyltransferase II, which transfers N-acetylglucosamine to the C-2 position of the Man alpha 1----6Man beta 1----arm of the biantennary core structure, was therefore examined by using Man alpha 1----6(GlcNAc beta 1----2Man alpha 1----3)Man beta 1----4GlcNAc beta 1----4GlcNAcol as an acceptor. N-Acetylglucosaminyltransferase II activity was demonstrated in the lymphocyte microsome fraction from normal individuals. However, this enzyme activity was found to be decreased in those from HEMPAS patients. These results suggest that the primary defect of HEMPAS lies in the lowered activity of N-acetylglucosaminyltransferase II.
D000606:Amino Sugars / Q000097:blood*; D000742:Anemia, Dyserythropoietic, Congenital / Q000201:enzymology* / Q000235:genetics; D000745:Anemia, Hemolytic, Congenital / Q000201:enzymology*; D001457:Anion Exchange Protein 1, Erythrocyte / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism*; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D004912:Erythrocytes / Q000378:metabolism*; D005964:Glucosyltransferases / Q000097:blood / Q000172:deficiency*; D006020:Glycopeptides / Q000097:blood; D006031:Glycosylation; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology; D013058:Mass Spectrometry; D008861:Microsomes / Q000378:metabolism; D017351:N-Acetylglucosaminyltransferases; D011134:Polysaccharides / Q000097:blood*; D012156:Reticulocytes / Q000378:metabolism; D012844:Sincalide / Q000031:analogs & derivatives* / Q000494:pharmacology
D000606:Amino Sugars; D001457:Anion Exchange Protein 1, Erythrocyte; D001798:Blood Proteins; D006020:Glycopeptides; D011134:Polysaccharides; C039448:lactosaminoglycan; C052607:t-butyloxycarbonyl-(sulfo-Tyr)-Met-Gly-Trp-Nle-Asp 2-phenylethyl ester; D005964:Glucosyltransferases; D017351:N-Acetylglucosaminyltransferases; C063313:alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase; D012844:Sincalide